Biosecurity Modernization and Innovation Act of 2026
INTRO JAN 29· LAST ACTION JAN 29
READING
12MIN
COSPONSORS
5BIPARTISAN
READER REACTIONS0 TOTAL
NO VOTES YET · BE THE FIRST
Introduced only
LEGISLATIVE PROGRESS
STEP 2 / 8
Introduced
In Committee
Reported
Passed Senate
Passed House
Conference
To President
Became Law
WHAT THE BILL DOES
AI-written
This bill matters because rapid advancements in biotechnology, specifically in making synthetic genetic material, present both incredible opportunities and serious risks. With synthetic biology becoming easier and cheaper, there's a growing concern that harmful actors could misuse this technology to create dangerous biological weapons or new pandemic-causing viruses.
If this bill becomes law, it would establish a nationwide standard for screening synthetic DNA orders and customers, aiming to close current security gaps and prevent potential biothreats. Without this law, oversight might remain fragmented and potentially inadequate to keep pace with technological advancements, leaving the nation more vulnerable to biological attacks or accidental pathogen releases. It seeks to strike a balance between fostering innovation in biotechnology and protecting public health and national security.
KEY PROVISIONS
5AI-extracted
PROVISION 01
Requires companies that make or sell synthetic genetic materials or related equipment to screen all orders for dangerous sequences and verify customer identity.
This is crucial for preventing malicious actors from obtaining materials that could be used to create harmful biological agents.
PROVISION 02
Establishes a government-maintained list of 'sequences of concern' that must be screened for, with a system for regular updates and public input.
A regularly updated list ensures that screening protocols remain relevant to emerging biological threats and incorporate the latest scientific understanding.
PROVISION 03
Mandates a conformity assessment system, including audits and 'red-teaming' (simulated attacks) to ensure companies are following the new security rules.
This provision ensures accountability and verifies that security protocols are effective and being properly implemented by providers.
PROVISION 04
Requires recipients of federal funding to purchase synthetic genetic products only from providers that comply with these new security requirements.
This strengthens the impact of the regulations by creating an incentive for providers to comply and ensures federally funded research adheres to high security standards.
PROVISION 05
Includes safeguards to prevent unnecessary burdens on innovation, such as expedited review for legitimate institutional customers and exemptions for clearly non-hazardous products.
These safeguards are intended to ensure that security measures do not unduly stifle scientific research and development in biotechnology.
This bill matters because rapid advancements in biotechnology, specifically in making synthetic genetic material, present both incredible opportunities and serious risks. With synthetic biology becoming easier and cheaper, there's a growing concern that harmful actors could misuse this technology to create dangerous biological weapons or new pandemic-causing viruses.
If this bill becomes law, it would establish a nationwide standard for screening synthetic DNA orders and customers, aiming to close current security gaps and prevent potential biothreats. Without this law, oversight might remain fragmented and potentially inadequate to keep pace with technological advancements, leaving the nation more vulnerable to biological attacks or accidental pathogen releases. It seeks to strike a balance between fostering innovation in biotechnology and protecting public health and national security.
KEY PROVISIONS
AI-extracted
high
Requires companies that make or sell synthetic genetic materials or related equipment to screen all orders for dangerous sequences and verify customer identity.
This is crucial for preventing malicious actors from obtaining materials that could be used to create harmful biological agents.
high
Establishes a government-maintained list of 'sequences of concern' that must be screened for, with a system for regular updates and public input.
A regularly updated list ensures that screening protocols remain relevant to emerging biological threats and incorporate the latest scientific understanding.
med
Mandates a conformity assessment system, including audits and 'red-teaming' (simulated attacks) to ensure companies are following the new security rules.
This provision ensures accountability and verifies that security protocols are effective and being properly implemented by providers.
med
Requires recipients of federal funding to purchase synthetic genetic products only from providers that comply with these new security requirements.
This strengthens the impact of the regulations by creating an incentive for providers to comply and ensures federally funded research adheres to high security standards.
low
Includes safeguards to prevent unnecessary burdens on innovation, such as expedited review for legitimate institutional customers and exemptions for clearly non-hazardous products.
These safeguards are intended to ensure that security measures do not unduly stifle scientific research and development in biotechnology.
Not later than 1 year after the date of the enactment of this Act
Secretary of Commerce must establish and maintain regulations to improve nucleic acid synthesis security.
GLOSSARY
AI-written
Nucleic acid synthesis
The process of creating artificial DNA or RNA sequences in a laboratory.
Synthetic nucleic acids
Artificially created DNA or RNA molecules, often used in scientific research or to produce biological products.
Covered provider
A person or company that makes and sells synthetic DNA/RNA or the equipment used to make them, to people in the U.S.
Sequences of concern
Specific genetic sequences (DNA or RNA) identified by the government as potentially dangerous or usable for harmful purposes, such as creating pathogens.
Conformity assessment system
A system for checking and verifying that companies are following the required security standards and rules.
Adversarial testing ('red-teaming')
A security practice where a team simulates an attack or tries to find weaknesses in a system to test its defenses.
Benchtop synthesizers
Compact laboratory machines used to create synthetic DNA or RNA sequences.
ACTION TIMELINE
2 EVENTS
JAN 29
Introduced in Senate
INTROREFERRAL
JAN 29
Read twice and referred to the Committee on Commerce, Science, and Transportation.